1.Early carotid artery stenting for the treatment of cerebral watershed infarction:a clinical analysis
Huakun LIU ; Lei ZHANG ; Chaolai LIU ; Zhongrui YAN ; Jianfeng CHU
Journal of Interventional Radiology 2014;(9):749-752
Objective To evaluate the safety and efficacy of early carotid artery stenting in treating cerebral watershed infarction patients with carotid artery stenosis. Methods A total of 33 patients with acute cerebral watershed infarction complicated by carotid artery stenosis received carotid artery stenting within one week after the onset of the disease. The clinical safety and efficacy were evaluated. Results The carotid artery stenting was successfully accomplished in all 33 patients with a success rate of 100%. After the procedure, different degree of bradycardia and hypotension was seen in 23 patients, which restored to normal after prompt medication with atropine, dopamine, etc. During the procedure, one patients developed cerebral embolism due to dislodgment of emboli, resulting in contralateral hemiparalysis, and the contralateral limb muscle strength returned to preoperative status after proper treatment. After the treatment, no ipsilateral hemisphere excessive perfusion or cerebral hemorrhage occurred. Thirty days after the treatment, NHISS scores of the patients were obviously improved, which were significantly different from those determined before the treatment (P<0.05). Conclusion For the treatment of acute cerebral watershed infarction, early carotid artery stenting to relieve carotid artery stenosis is quite safe and it may improve the prognosis as well.
2.Carotid stenting for progressive cerebral watershed infarction patients with ipsilateral internal carotid stenosis or occlusion
Huakun LIU ; Lei ZHANG ; Zhongrui YAN ; Shengnian ZHOU ; Jianfeng CHU
International Journal of Cerebrovascular Diseases 2016;24(3):214-218
Objective To investigate the effectiveness and safety of carotid stenting for progressive cerebral watershed infarction (PCWI) patients with ipsilateral internal carotid stenosis or occlusion during the progressive stage. Methods The clinical data of 23 PCWI patients with ipsilateral internal carotid stenosis or occlusion treated with carotid stenting during the progressive stage were analyzed retrospectively. Among them, 18 were severe internal carotid artery stenosis, and 5 were carotid artery occlusion. Carotid artery stenting were performed in patients with severe internal carotid artery stenosis. The first-stage angioplasty and second-stage stenting were performed in patients with internal carotid artery occlusion. The National Institutes of Health Stroke Scale (NIHSS) score and the modified Rankin scale (mRS) were used to evaluate preoperative and postoperative neurologic deficits. Results Twenty-two of 23 patients were stented successfuly, the Thrombolysis In Myocardial Infarction (TIMI) flow grade was 3, and the technical success rate was 95. 7% . None of the patients demonstrated hyperperfusion in the ipsilateral hemisphere. At day 30 postprocedure, the NHISS scores were significantly improved compared with before procedure (4. 41 ± 1. 88 vs. 10. 00 ± 1. 47; t = 11. 234, P < 0. 001). The preprocedural TIMI flow grade was 3 in 12 patients (52. 2% ). Proportion of patients with TIMI flow grade 3 after procedure was significantly increased compared with before procedure (95. 7% vs. 52. 2% ; χ2 = 11. 274, P = 0. 002). The proportion of patients with mRS scores 0-2 at day 90 after procedure was significantly increased compared with before procedure (69. 6% vs. 0% ; χ2 = 24. 533, P < 0. 001). Conclusions Carotid stenting during the progressive stage is safe and it may improve the prognosis in PCWI patients with ipsilateral internal carotid stenosis or occlusion.
3.Capsular warning syndrome
International Journal of Cerebrovascular Diseases 2021;29(12):926-930
Capsule warning syndrome (CWS) is a special clinical subtype of transient ischemic attack involving internal capsule, no cortical involvement and showing stereotyped attack. Although CWS is rare in clinical practice, most patients have poor outcomes. Therefore, a comprehensive and in-depth understanding of CWS is helpful to improve the outcomes and quality of life of patients. This article reviews the recent research progress of CWS.
4.Karyotype analysis of chorionic villi from pregnant women with missed abortion using multiplex ligation-dependent probe amplification
Yan GU ; Jiansheng XIE ; Fuwei LUO ; Qian GENG ; Huakun ZHANG ; Huining SHEN ; Kun ZHAO ; Qingzhi LIU
Chinese Journal of Obstetrics and Gynecology 2009;44(7):509-513
Objective To evaluate the clinical value of multiplex ligation-dependent probe amplification (MLPA) technique used in karyotype analysis of chorionic villi from missed abortion. Methods Feb 2008 to Oct 2008, 91 patients with missed abortion diagnosed by hormonal measurement, type B ultrasound and physical exam matched with 20 normal pregnant women undergoing artificial abortion were enrolled in this study. Chorionic villi was obtained by suction dilation and curettage in aseptic condition, then those villi was cultured and analyzed by traditional cytogenetic karyotyping method, in the mean time, the DNA extracted from villi was detected by MLPA. The results of chromosomal G-banding of chorionic villi were compared between two methods. Results The diagnostic concordance of MLPA and traditional karyotyping was observed in 92% (84/91) cases, there were 84 cases in the case group with diagnostic concordance by traditional karyotyping and MLPA except 7 cases of euploidy could not be detected by MLPA. The 84 cases included 40 normal karyotype,29 trisomy of euchromosome, 1 double trisomy of euchromosome, 10 monosomy X , 1 monosomy X combined with trisomy of euchromosome, 2 chimaera of X chromosome, 1 structural abnormity of euchromosome. Among 7 cases with discordance diagnosis, 2 cases with trisomy and 5 cases with tetrasomy of euchromosome were identified in traditional karyotyping, however, they were all diagnosed with normal disomy by MLPA. Of 20 villi from normal pregnancy, two methods got the consistent results. Conclusion The MLPA was rapid and efficacy method used for analyzing aneuploids in chorionic villi.
5.Endovascular treatment of acute ischemic stroke due to primary medium vessel occlusion: a retrospective case series of 17 patients
Yusen CAI ; Yanhong WANG ; Zhipeng GUO ; Huakun LIU
International Journal of Cerebrovascular Diseases 2022;30(8):561-568
Objective:To investigate the efficacy and safety of endovascular treatment (EVT) in patients with acute ischemic stroke due to acute primary medium vessel occlusion (MeVO).Methods:Patients with primary MeVO received EVT in the stroke center of Jining First People's Hospital from January 2019 to January 2022 were enrolled retrospectively. MeVO was defined as occlusion of M2/M3 segment of middle cerebral artery, A2/A3 segment of anterior cerebral artery and P2/P3 segment of posterior cerebral artery. The symptoms, vascular recanalization and surgical complications were documented. The National Institutes of Health Stroke Scale (NIHSS) score at discharge and the modified Rankin Scale (mRS) score at 90 d after onset were followed up.Results:A total of 17 patients with primary MeVO were included, among them 16 successfully achieved vascular recanalization, 1 had distal emboli escape, and 1 had asymptomatic intracranial hemorrhage. There was significant difference in NIHSS scores before and after thrombectomy ( P<0.01). Ten patients (62.5%) had good functional outcome (mRS score 0-2), and 1 died of secondary pulmonary infection at 20 d after procedure. Conclusion:After strict risk/benefit evaluation and screening, EVT of acute ischemic stroke due to primary MeVO was technically feasible, and had good efficacy and safety.
6.Management of risk factors for intracranial atherosclerotic stenosis
Yang LU ; Huakun LIU ; Jianfeng CHU
International Journal of Cerebrovascular Diseases 2024;32(8):620-623
Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of ischemic stroke worldwide. A variety of factors are associated with the occurrence and development of ICAS, including gender, age, persistent inflammatory state, hypertension, hyperlipidemia and diabetes. Early identification and appropriate management of risk factors for ICAS are of great significance for actively preventing and treating ICAS and reducing the risk of ischemic stroke occurrence and recurrence.
7.Role of homocysteinylation in cerebral atherosclerosis
Zhipeng GUO ; Huakun LIU ; Yanhong WANG
International Journal of Cerebrovascular Diseases 2023;31(4):298-302
Homocysteine is closely associated with extracranial and intracranial atherosclerosis, and its main pathogenesis includes oxidative stress, lipid metabolism disorder and vascular endothelial dysfunction. As a protein modification related to homocysteine, homocysteinylation can promote the occurrence and development of cerebral atherosclerosis by promoting oxidation, changing lipid function and destroying vascular endothelial function. This article reviews the role of homocysteinylation in cerebral atherosclerosis, and discusses the possibility of preventing cerebral atherosclerosis by homocysteinylation.
8.Clinical evaluation of rapid prenatal detection of aneuploid abnormalities with multiplex ligationdependent probe amplification
Caiqun LUO ; Jiansheng XIE ; Weiqing WU ; Hui YUAN ; Zhiyong XU ; Fuwei LUO ; Qian GENG ; Huakun ZHANG ; Ying HAO ; Hong LIU
Chinese Journal of Laboratory Medicine 2012;35(2):160-164
Objective To estimate clinical application of multiplex ligation-dependent probe amplification (MLPA) for rapid prenatal detection of aneuploid abnormalities in amniotic fluid.Methods Totally 1229 amniotic fluid samples were collected from the pregnant women receving prenatal diagnosis for chromosomal abnormalities in Prenatal Diagnosis Center of Shenzhen Maternity and Child Healthcare Hospital from October 2009 to December 2010.All the samples were investigated independently with both MLPA and G-band karyotyping to detect aneuploidies of chromosomes X,Y,13,18 and 21.A comparison was followed the results acquired from two methods for evaluation of sensitivity and specificity of MLPA.ResultsThirtyeight aneuploidies were detected by G-band karyotyping,in which 34 were nonmosaic aneuploidies and 4were mosaic aneuploidies.MLPA and G-band karyotyping had consistent results in detecting the nonmosaic aneuploidies of chromosomes X,Y,13,18 and 21. Among 4 mosaic aneuploidies detected by G-band karyotyping,2 were confirmed by MLPA independently.Conclusions The sensitivity and specificity of MLPA in detecting the nonmosaic aneuploidies of chromosomes X,Y,13,18 and 21 were clinically acceptable.MLPA provides an efficient,reliable method for rapid detection of aneuploidies.
9.A nomogram prediction model based on imaging markers of cerebral small vessel disease for short-term poor outcome after intravenous thrombolysis in patients with acute ischemic stroke
International Journal of Cerebrovascular Diseases 2024;32(4):247-253
Objective:To develop a nomogram model for predicting short-term poor outcome after intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS) based on imaging markers of cerebral small vessel disease (CSVD).Methods:Patients with AIS received intravenous thrombolysis treatment at Jining No. 1 People's Hospital from January 2021 to December 2023 were retrospectively included. MRI was used to evaluate imaging markers of CSVD, including lacunar infarction (LI), cerebral microbleeds (CMBs), white matter hyperintensities (WMHs), and enlarged perivascular spaces (EPVS). The outcome evaluation was performed at 90 days after onset using the modified Rankin Scale, and the score of >2 was defined as poor outcome. LASSO regression analysis was used to screen the variables most correlated with poor outcome after intravenous thrombolysis, and construct a nomogram for predicting poor outcome through a logistic regression model. The predictive ability of the nomogram was verified through the receiver operating characteristic curve, calibration chart, and decision curve analysis. Results:A total of 167 patients were included, of which 96 (57%) had good outcome and 71 (43%) had poor outcome. The variables with P<0.05 in univariate analysis were included in the LASSO regression model to screen for variables. Finally, left side infarction, atrial fibrillation, baseline systolic blood pressure, baseline National Institutes of Health Stroke Scale (NIHSS) score, high-density lipoprotein cholesterol, WMHs (1 point), CMBs (1 point), EPVS (1 point), LI (1 point), and overall CSVD load (2-4 points) were included in the multivariate logistic regression analysis. The results showed that atrial fibrillation (odds ratio [ OR] 6.75, 95% confidence interval [ CI] 1.49-41.40; P=0.022), baseline systolic blood pressure ( OR 1.01, 95% CI 1.00-1.04; P=0.049), baseline NIHSS score ( OR 1.47, 95% CI 1.23-1.80; P<0.001), WMHs ( OR 3.40, 95% CI 1.28-9.53; P=0.015), CMBs ( OR 3.24, 95% CI 1.12-9.90; P=0.032) and EPVS ( OR 2.89, 95% CI 1.05-8.23; P=0.041) were the independent risk factors for poor outcome. The nomogram model was developed using these variables. The receiver operating characteristic curve analysis showed that the area under the curve was 0.885 (95% CI 0.837-0.933; P<0.01), indicating that the model had good discrimination. The consistency between the predicted and actual values of the nomogram model was good. Conclusion:The nomogram model for predicting the probability of poor outcome developed from atrial fibrillation, baseline systolic blood pressure, baseline NIHSS score, WMHs, CMBs, and EPVS has good discrimination and calibration, and has certain clinical practicality.
10.Risk factors for in-stent restenosis in patients with severe symptomatic intracranial carotid stenosis
Xiuyu WANG ; Huakun LIU ; Jianfeng CHU
International Journal of Cerebrovascular Diseases 2024;32(4):254-259
Objective:To investigate risk factors for in-stent restenosis (ISR) after percutaneous transluminal angioplasty and stenting (PTAS) in patients with severe symptomatic intracranial carotid stenosis.Methods:Consecutive patients with severe symptomatic intracranial carotid stenosis underwent PTAS in the Department of Neurology, Jining First People's Hospital from December 2021 to June 2023 were retrospectively included. Clinical and procedure related data were collected, and periprocedural complications were recorded. Imaging follow-up was used to evaluate ISR after 6 months. Multivariate logistic regression analysis was used to determine independent risk factors for ISR. Results:A total of 73 patients were enroled, including 45 males (61.6%), aged 61.49±7.78 years. The median follow-up time was 8 months (interquartile range, 7-9 months; range, 6-10 months), with 19 cases (26.0%) experiencing ISR, of which 1 (1.4%) had symptomatic ISR. Multivariate logistic regression analysis showed that the higher degree of residual stenosis immediately after procedure (odds ratio [ OR] 1.102, 95% confidence interval [ CI] 1.004-1.209; P=0.040), accompanied by moderate to severe cerebrovascular stenosis in other areas ( OR 6.638, 95% CI 1.106-39.835; P=0.038) and low preprocedural white blood cell count ( OR 0.541, 95% CI 0.308-0.952; P=0.033) were the independent risk factors for ISR. Conclusion:The higher degree of residual stenosis immediately after procedure, accompanied by moderate to severe cerebrovascular stenosis in other areas, and lower preprocedural white blood cell count are the risk factors for the occurrence of ISR after PTAS in patients with severe intracranial carotid stenosis.